Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2020

Jan 8, 2020

31210_dirs_2020-01-08_140a2c15-9729-4c55-a372-4d2bf9d4ff31.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2019-10-15

Reporting Person: Sherras Brian R (Former Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 27965 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options to purchase Common Stock $ Common Stock (35000) 35000 Direct

Footnotes

F1: Electrigen Limited ("Electrigen") acquired the common stock of the Issuer in exchange for Electrigen's ownership interest in Atlantic Projects Company Limited having an estimated value of $917,531.65. The Reporting Person is 50% owner and director of Electrigen; therefore, the Reporting Person may be deemed to indirectly beneficially own the shares owned by Electrigen.

F2: As of the date of this filing, the total number of stock options owned by the Reporting Person includes options to acquire an aggregate number of 35,000 shares of the Issuer's common stock as follows: 1) options to purchase 5,000 shares awarded on 4/2/12 at an exercise price per share of $16.47; 2) options to purchase 10,000 shares awarded on 12/18/12 at an exercise price per share of $18.87; 3) options to purchase 10,000 shares awarded on 12/17/13 at an exercise price per share of $26.88; and 4) options to purchase 10,000 shares awarded on 12/11/14 at an exercise price per share of $31.82. Each set of options became exercisable on the first anniversary of the corresponding award date. All of these stock options will expire on 10/15/20.